Ironwood Pharmaceuticals
IRWD
IRWD
251 hedge funds and large institutions have $1.91B invested in Ironwood Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 87 increasing their positions, 94 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4.72% more ownership
Funds ownership: 102.33% → 107.05% (+4.7%)
1% more funds holding
Funds holding: 248 → 251 (+3)
7% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 94
Holders
251
Holding in Top 10
2
Calls
$24.5M
Puts
$11.5M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$25.7M | |
| 3 | +$16.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$12.7M |
Top Sellers
| 1 | -$27.9M | |
| 2 | -$13M | |
| 3 | -$10.9M | |
| 4 |
Two Sigma Investments
New York
|
-$9.25M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$5.76M |